Phase 1 biotech developing gene edited cell therapies for multiple cancers.
Industry: Health Care
Latest Trade: $1.87 0.00 (0.0%)
First Day Return: +2.0%
Return from IPO: -88.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/01/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 19.0 |
Deal Size ($mm) | $304 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/22/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 19.0 |
Deal Size ($mm) | $304 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Citi |
more |
Company Data | |
---|---|
Headquarters | Berkeley, CA, United States |
Founded | 2011 |
Employees at IPO | 67 |
Website www.cariboubio.com |